StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) stock

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.52−0.09 (-5.30%)

Close on Nov 17, 2026Market cap $24.93MP/E –Yield –

Cellyan Biotechnology cash

Cash and short-term investments held at the end of each period.

Cellyan Biotechnology's cash was $221.84K at Mar 31, 2026. For fiscal 2026 it was $221.84K, down 70.4% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2026Mar 31, 2026$221.84K-70.4%
FY2025Mar 31, 2025$748.72K+20.8%
FY2024Mar 31, 2024$619.58K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ1 2026Mar 31, 2026$221.84K–
Q2 FY2026CQ3 2025Sep 30, 2025$190.91K–
Q4 FY2025CQ1 2025Mar 31, 2025$748.72K–
Q4 FY2024CQ1 2024Mar 31, 2024$619.58K–

More Cellyan Biotechnology figures

See a number that looks wrong?